A proteomic analysis of liver after ethanol binge in chronically ethanol treated rats

Proteome Science

Volumn 10, Issue 1, 2012, Pages

  Aroor, Annayya R ^a   Roy, Lowery J ^b   Restrepo, Ricardo J ^a   Mooney, Brian P ^a,b   Shukla, Shivendra D ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Binge ethanol; Chronic ethanol; Liver proteomics

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL; CARBONATE DEHYDRATASE III; CYTOCHROME P450 2E1; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE TRANSFERASE; HISTONE H2AX; ISOCITRATE DEHYDROGENASE;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY LIVER; HISTONE PHOSPHORYLATION; LIVER EXAMINATION; LIVER NECROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

RATTUS;

EID: 84862155823     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-10-29     Document Type: Article

References (58)

1. Adachi A, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig Dis 2005, 23:255-263. 10.1159/000090173, 16508290.
2. dela Hall MP, Lieber CS, DeCarli LM, French SW, Lindros KO, Jarvelainen H, Bode C, Parlesak A, Bode JC. Models of alcoholic liver disease in rodents. A critical evaluation. Alcoholism Clin Exp Res 2001, 25:254S-261S.
3. Kotesh A, Yang S, Lin H, Huang X, Diehl AM. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting jun N-terminal kinase and caspase 3 activation. J Biol Chem 2002, 44:13037-13044.
4. Schafer C, Parlesak A, Schutt C, Bode C, Bode JC. Concentrations of lipopolysaccharide binding protein, bactericidal/ permeability-increasing protein, soluble CD-14 and plasma lipids in relation to endotoxemia in patients with alcoholic liver disease. Alcohol Alcohol 2002, 37:81-86.
5. Fukui H. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic injury and multiple organ failure. Alcoholism Clin Exp Res 2005, 29:172-179S.
6. Rivara PF, Jurkovich GJ, Gurney GJ, Seguin D, Fligner CL, Ries R, Raisvs VA, Copass M. The magnitude of acute and chronic alcohol abuse in trauma patients. Arch Surg 1993, 128:907-913. 10.1001/archsurg.1993.01420200081015, 8102049.
7. Crosse KI, Anania FK. Alcoholic hepatitis. Curr Treat Options in Gastroenterol 2002, 5:417-423.
8. Ceccanti M, Attili A, Balducci B, Attilia F, Giacomelli S, Rotondo C, Sasso GF, Xerouchakis E, Attilia ML. Acute alcoholic hepatitis. J Clin Gastroenterol 2006, 40:833-841. 10.1097/01.mcg.0000225570.04773.5d, 17016141.
9. Zakhari S, Li TK. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 2007, 46:2032-2039. 10.1002/hep.22010, 18046720.
10. Mathurin P, Deltenre P. Effect of binge drinking on the liver: an alarming public health issue?. Gut 2009, 58:613-617. 10.1136/gut.2007.145573, 19174416.
11. Mathurin P, Beuzin PF, Louvet A, Carrie-Ganne N, Balian NA, Dalsoglio D, Trinchetet TC, Prevot S, Naveav S. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 2007, 25:1047-1054. 10.1111/j.1365-2036.2007.03302.x, 17439505.
12. Aroor AR, Jackson DE, Shukla SD. Elevated activation of erk1 and erk2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats. Alcoholism Clin Exp Res 2011, 35:2128-2138.
13. Gstaiger M, Aebersold R. Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat Rev Genet 2009, 10:617-627. 10.1038/nrg2633, 19687803.
14. Mas RV, Fisher RA, Archer KJ, Maluf DG. Proteomics and liver fibrosis: identifying markers of fibrogenesis. Exper Trev Proteomics 2009, 6:421-431.
15. Uto H, Kanumra S, Takami Y, Tsubouchi H. Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. Proteome Science. 2010, 8:70. 10.1186/1477-5956-8-70, 3023778, 21192835.
16. Beretta L. Liver proteomics applied to translational research in liver disease and cancer. Proteomics Clin Appl 2010, 4:359-361.
17. Bailey SM, Andringa KK, Landar A, Darley-Usmar VM. Proteomic approaches to identify and characterize alterations to the mitochondrial proteome in alcoholic liver disease. Methods Mol Biol 2008, 447:369-380. 10.1007/978-1-59745-242-7_24, 2935618, 18369930.
18. Banerjee A, Russell WK, Jayaraman A, Ramaiah SK. Identification of proteins to predict the molecular basis for the observed gender susceptibility in a rat model of alcoholic steatohepatitis by 2-D gel proteomics. Proteomics 2008, 8:4327-4337. 10.1002/pmic.200700368, 18924223.
19. Kharbanda KK, Vigneswara V, McVicker BL, Newlaczyl AU, Bailey K, Tuma D, Ray DE, Carter WG. Proteomics reveal a concerted upregulation of methionine metabolic pathway enzymes, and downregulation of carbonic anhydrase-III, in betaine supplemented ethanol-fed rats. Biochem Biophys Res Commun 2009, 381:523-527. 10.1016/j.bbrc.2009.02.082, 2670967, 19239903.
20. Shepard BD, Tuma DJ, Tuma PL. Chronic ethanol consumption induces global hepatic protein hyperacetylation. Alcohol Clin Exp Res 2010, 34:280-291. 10.1111/j.1530-0277.2009.01091.x, 2957803, 19951295.
21. Andringa KK, King AL, Eccleston HB, Mantena SK, Landar A, Jhala NC, Dickinson DA, Squadrito GL, Bailey SM. Analysis of the liver mitochondrial proteome in response to ethanol and S-adenosylmethionine treatments: novel molecular targets of disease and hepatoprotection. Am J Physiol Gastrointest Liver Physiol 2010, 298:G732-G745. 10.1152/ajpgi.00332.2009, 2867419, 20150243.
22. Newton BW, Russel WK, Russel DH, Ramaiah S, Jayaraman. A liver proteome analysis in a rodent model of alcoholic steatosis. J Proteome Res 2009, 8:1663-1671. 10.1021/pr800905w, 2888666, 19714808.
23. Kita K, Okumura N, Takao T, Watanabe M, Matsubara T, Nishimura O, Nagai K. Evidence for phosphorylation of rat liver glucose-regulated protein 58, GRP58/ERp57/ER-60, induced by fasting and leptin. FEBS Lett 2005, 580:199-205.
24. Räisänen SR, Lehenkari P, Tasanen M, Rahkila P, Härkönen PL, Väänänen HK. Carbonic anhydrase III protects cells from hydrogen peroxide induced apoptosis. FASEB J 1999, 13:513-522.
25. Lee SM, Koh HJ, Park DC, Song BJ, Huh TL, Park JW. Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 2002, 32:1185-1196. 10.1016/S0891-5849(02)00815-8, 12031902.
26. Cederbaum AI. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig Dis 2010, 28:802-811. 10.1159/000324289, 3211519, 21525766.
27. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 2008, 44:723-738. 10.1016/j.freeradbiomed.2007.11.004, 2268632, 18078827.
28. Smathers RL, Galligan JJ, Stewart BJ, Petersen DR. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem Biol Interact 2011, 192:107-112. 10.1016/j.cbi.2011.02.021, 3109208, 21354120.
29. Sampey BP, Korourian S, Ronis MJ, Badger TM, Petersen DR. Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcohol Clin Exp Res 2003, 27:1015-1122. 10.1111/j.1530-0277.2003.tb04430.x, 2956497, 12824824.
30. Poli G, Biasi F, Leonarduzzi G. 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol Aspects Med 2008, 29:67-71. 10.1016/j.mam.2007.09.016, 18158180.
31. Xu D, Perez RE, Rezaiekhaligh MH, Bourdi M, Truog WE. Knockdown of ERp57 increases BiP/GRP 78 induction and protects against hyperoxia and tunicamycin-induced apoptosis. Am Physiol Lung Cell Mol Physiol 2009, 297:L44-L51.
32. Krynetskaia NF, Phadke MS, Jadhav SH, Krynetskiy EY. Chromatin-associated proteins HMG1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol Cancer Ther 2009, 8:864-872. 10.1158/1535-7163.MCT-08-0695, 2684979, 19372559.
33. Tadic SD, ELM MS, Li H, Van London GJ, Subbotin VM, Whitcomb DC, Eagon PK. Sex differences in hepatic gene expression in a rat model of ethanol-induced liver injury. J Appl Physiol 2002, 93:1057-1068.
34. Mallis RJ, Hamann MJ, Zhao W, Zhang T, Hendrich S, Thomas JA. Irreversible thiol oxidation in carbonic anhydrase III: protection by S-glutathiolation and detection in aging rats. Biol Chem 2002, 383:649-662.
35. Zimmerman UJ, Wang P, Zhang X, Bogdanovich S, Forster R. Anti-oxidative response of carbonic anhydrase III in skeletal muscle. IUBMB Life 2004, 56:343-347. 10.1080/1521-6540400000850, 15370882.
36. Lii CK, Chai YC, Zhao W, Thomas JA, Hendrich S. S-Thiolation and irreversible oxidation of sulfhydryls on carbonic anhydrase III during oxidative stress: a method for studying protein modification in intact cells and tissues. Arch Biochem Biophys 1994, 308:231-239. 10.1006/abbi.1994.1033, 8311458.
37. Kanbagli O, Balkan J, Aykac-Toker G, Uysal M. Hepatic Mitochondrial Prooxidant and Antioxidant Status in Ethanol-Induced Liver Injury in Rats. Biol Pharm Bull 2002, 25:1482-1484. 10.1248/bpb.25.1482, 12419965.
38. Parkkila S, Halsted CH, Villanueva JA, Vaananen HK, Niemela O. Expression of testerone dependent enzyme carbonic anhydrase III and oxidative stress in experimental alcoholic liver disease. Dig Dis Sci 1999, 44:2205-2213. 10.1023/A:1026640317233, 10573363.
39. Brown SM, Upadhya R, Shoemaker JD, Lodge JK. Isocitrate dehydrogenase is important for nitrosative stress resistance in Cryptococcus neoformans, but oxidative stress resistance is not dependent on glucose-6-phosphate dehydrogenase. Eukaryot Cell 2010, 9:971-980. 10.1128/EC.00271-09, 2901651, 20400467.
40. Yang SE, Lee SM, Park WJ. Silencing of NADP-dependent isocitrate dehydrogenase gene enhances ethanol-induced cytotoxicty in Hep G2 cells. Arch Pharm Res 2010, 33:1065-1071. 10.1007/s12272-010-0713-4, 20661717.
41. Lee JH, Yang ES, Park JW. Inactivation of NADP + dependent isocitrate dehydrogenase by peorxynitrite. Implications for cytotoxicity and alcohol-induced liver injury. J Biol Chem 2003, 278:51360-51371. 10.1074/jbc.M302332200, 14551203.
42. Desjardins P, Rama Rao KV, Michalak A, Butterworth RF RC. Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in Brain , liver and skeletal muscle. Metabol Brain Dis 1999, 14:273-280.
43. Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology 1997, 25:351-355. 10.1002/hep.510250216, 9021946.
44. Abraham P, Wilfred G, Ramakrishna B. Oxidative damage to the hepatocellular proteins after chronic ethanol intake in the rat. Clin Chim Acta 2002, 325:117-125. 10.1016/S0009-8981(02)00279-6, 12367775.
45. Khan AJ, Choudhuri G, Husain Q, Parmar D. Polymorphisim glutathione -S-transferases: a risk factor for alcoholic liver cirrhosis. Drug Alcohol Dep. 2009, 101:183-190.
46. Chen J, Schenker S, Henderson GI. 4-hydroxynonenal detoxification by mitochondrial glutathione-S transferase is compromised by short-term ethanol consumption in rats. Alcoholism Clin Exp Res. 2002, 26:1252-1258.
47. Vanhaecke T, Lindros KO, Oinonen T, Coecke S, Debast G, Philips IR, Shepard EA, Vercruysse A, Rogiers V. Effect of ethanol on the expression of hepatic glutathione S transferase. An in vivo/invitro study. Biochemical Phramacol 2000, 60:1491-1496.
48. Brind AM, Hurlstone A, Edrisinghe D, Gilmore I, Fisher N, Pirmohamed M, Fryer AA, Brind AM, Hurlstone A, Edrisinghe D, Gilmore I, Fisher N, Pirmohamed M, Fryer AA. The role of polymorphisms of glutathione s-transferase GSTM1, M3, Pi, T1 and A1 in susceptibility to alcoholic liver disease. Alcohol Alcohol 2004, 39:478-483.
49. Pal-Bhadra M, Bhadra U, Jackson DE, Mamatha L, Park PH, Shukla SD. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes. Life Sci 2007, 81:979-987. 10.1016/j.lfs.2007.07.030, 2706023, 17826801.
50. Josephy PD. Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Human Genomics Proteomics 2010, ID 876940.
51. Ellgaard L, Frickel EM. Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding. Cell Biochem Biophys 2003, 39:223-247. 10.1385/CBB:39:3:223, 14716078.
52. Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett 2007, 581:3641-3651. 10.1016/j.febslet.2007.04.045, 2040386, 17481612.
53. Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, Fimia GM, Kepp O, Piacentini M, Froehlich KU, van Endert P, Zitvogel L, Madeo F, Kroemer G. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 2008, 15:1499-1509. 10.1038/cdd.2008.67, 18464797.
54. Tokutomi Y, Araki N, Kataoka K, Yamamoto E, Kim-Mitsuyama S. Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysis. Biochem Biophys Res Commun 2007, 364:822-830. 10.1016/j.bbrc.2007.10.095, 17964282.
55. Turano C, Coppari S, Altieri F, Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol 2002, 193:154-163. 10.1002/jcp.10172, 12384992.
56. Mooney BP, Miernyk JA, Greenlief CM, Thelen JJ. Using quantitative proteomics of Arabidopsis roots and leaves to predict metabolic activity. Physiol Plant 2006, 128:237-250.
57. Havlis J, Thomas H, Sebela M, Shevchenko A. Fast-response proteomics by accelerated in-gel digestion of proteins. Anal Chem 2003, 75:1300-1306. 10.1021/ac026136s, 12659189.
58. Liu XW, Lu FG, Zhang GS, Wu XP, You Y, Ouyang CH, Yang DY. Proteomics to display tissue repair opposing injury response to LPS-induced liver injury. World J Gastroenterol 2004, 10:2701-2705.